Strategy is feasible for advanced cancers; 157 regimens were administered to 210 patients, including 103 personalized combos ...
Opportunities in the mRNA quality monitoring market include the rising demand for QC due to the expansion of mRNA ...
A new consensus document developed by The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium was published in JCO ...
The Global Cancer Biomarkers Market is projected to grow at a CAGR of 8.6% from 2026 to 2033, according to a new report ...
Published in JCO Precision Oncology, the new analytical validation standards offer an industry-wide protocol for test developersCHICAGO, Jan. 15, 2026 /PRNewswire/ -- A new consensus document ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback